Your browser doesn't support javascript.
loading
Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals.
Stenberg, Jenny; Henriksson, Catrin; Lindberg, Magnus; Furuland, Hans.
Afiliación
  • Stenberg J; Department of Medical Sciences, University Hospital, Entrance 40, 751 85, Uppsala, Sweden. jenny.stenberg@medsci.uu.se.
  • Henriksson C; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Lindberg M; Department of Health and Caring Sciences, University of Gävle, Gävle, Sweden.
  • Furuland H; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
BMC Nephrol ; 19(1): 121, 2018 05 23.
Article en En | MEDLINE | ID: mdl-29792174
ABSTRACT

BACKGROUND:

Inadequate volume control may be a main contributor to poor survival and high mortality in hemodialysis patients. Bioimpedance measurement has the potential to improve fluid management, but several dialysis centers lack an agreed fluid management policy, and the method has not yet been implemented. Our aim was to identify renal care professionals' perceived barriers and facilitators for use of bioimpedance in clinical practice.

METHODS:

Qualitative data were collected through four focus group interviews with 24 renal care professionals dieticians, nephrologists and nurses, recruited voluntarily from a nation-wide selection of hemodialysis centers, having access to a bioimpedance-device. The participants were connected to each other and a moderator via equipment for telemedicine and the sessions were recorded. The interviews were semi-structured, focusing on the participants' perceptions of use of bioimpedance in clinical practice. Thematic content analysis was performed in consecutive steps, and data were extracted by employing an inductive, interactive, comparative process.

RESULTS:

Several barriers and facilitators to the use of bioimpedance in clinical practice were identified, and a multilevel approach to examining barriers and incentives for change was found to be applicable to the ideas and categories that arose from the data. The determinants were categorized on five levels, and the different themes of the levels illustrated with quotations from the focus groups participants.

CONCLUSIONS:

Determinants for use of bioimpedance were identified on five levels 1) the innovation itself, 2) the individual professional, 3) the patient, 4) the social context and 5) the organizational context. Barriers were identified in the areas of credibility, awareness, knowledge, self-efficacy, care processes, organizational structures and regulations. Facilitators were identified in the areas of the innovation's attractiveness, advantages in practice, and collaboration. Motivation, team processes and organizational capacities appeared as both barriers and facilitators.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Actitud del Personal de Salud / Encuestas y Cuestionarios / Diálisis Renal / Personal de Salud / Grupos Focales / Insuficiencia Renal Crónica Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Actitud del Personal de Salud / Encuestas y Cuestionarios / Diálisis Renal / Personal de Salud / Grupos Focales / Insuficiencia Renal Crónica Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Suecia